STOCK TITAN

Benjamin Jackson of Intercontinental Exchange (NYSE: ICE) exercises options, sells shares, and gains new RSUs

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Intercontinental Exchange, Inc. president Benjamin Jackson reported several stock transactions on February 10, 2026. He exercised 12,861 employee stock options at an exercise price of $57.31 per share, receiving the same number of ICE common shares.

On the same day, he sold 12,861 shares of common stock in an open-market transaction at about $165.001 per share under a pre-approved Rule 10b5-1 trading plan. In connection with previously granted restricted stock units, 1,413 shares were withheld at $169.48 per share to satisfy tax obligations.

Jackson also acquired 10,921 restricted stock units as a new equity award that vests in three equal annual installments. Following these transactions, he held an aggregate of 175,200 ICE equity interests, including common stock, unvested RSUs and performance-based RSUs as described in the footnotes.

Positive

  • None.

Negative

  • None.

Insights

Routine mix of option exercise, planned sale, tax withholding, and new RSU grant; overall impact appears neutral.

Benjamin Jackson, president of Intercontinental Exchange, exercised 12,861 fully vested options at an exercise price of $57.31 and received the same number of common shares. He then sold 12,861 shares at about $165.001 per share in an open-market transaction executed under a Rule 10b5-1 trading plan effective as of November 3, 2025.

The filing also shows 1,413 shares withheld at $169.48 to cover taxes on vesting RSUs, plus a new grant of 10,921 RSUs vesting over three years. After these moves, Jackson’s beneficial holdings total 175,200 ICE equity interests, combining common shares and unvested units as detailed in the footnotes. This pattern looks like standard executive equity management rather than a thesis-changing signal.

Insider Jackson Benjamin
Role President
Sold 12,861 shs ($2.12M)
Type Security Shares Price Value
Exercise Employee Stock Option (right to buy) Holding 12,861 $0.00 --
Exercise Common Stock 12,861 $57.31 $737K
Sale Common Stock 12,861 $165.001 $2.12M
Tax Withholding Common Stock 1,413 $169.48 $239K
Grant/Award Common Stock 10,921 $0.00 --
Holdings After Transaction: Employee Stock Option (right to buy) Holding — 12,862 shares (Direct); Common Stock — 178,553 shares (Direct)
Footnotes (1)
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 3, 2025. The price range for the aggregate amount sold by the direct holder is $165.00 - $165.06. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Represents shares of restricted stock units issued to the filing person on February 10, 2025. The restricted stock units vest over three years (1/3 on February 10, 2026, 1/3 on February 10, 2027 and 1/3 on February 10, 2028). Of the 9,424 shares, 3,141 shares were issued on February 10, 2026, of which 1,413 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 6,283 shares are scheduled to be issued on the two remaining vesting dates and taxes for these future issuances will be withheld and reported at the time the shares are issued. Represents restricted stock units issued to the filing person on February 10, 2026. This award of restricted stock units vests over three years (1/3 on each anniversary of the award date). The common stock number referred in Table I is an aggregate number and represents 139,785 shares of common stock and 17,204 unvested restricted stock units ("RSUs"), and 18,211 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year. The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. These options are fully vested
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Jackson Benjamin

(Last) (First) (Middle)
5660 NEW NORTHSIDE DRIVE

(Street)
ATLANTA GA 30328

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Intercontinental Exchange, Inc. [ ICE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
President
3. Date of Earliest Transaction (Month/Day/Year)
02/10/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/10/2026 M 12,861(1) A $57.31 178,553 D
Common Stock 02/10/2026 S 12,861(1) D $165.001(2) 165,692 D
Common Stock 02/10/2026 F 1,413(3) D $169.48 164,279 D
Common Stock 02/10/2026 A 10,921(4) A $0 175,200(5)(6)(7) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right to buy) Holding $57.31 02/10/2026 M 12,861 (8) 01/18/2027 Common Stock 12,861 $0 12,862 D
Explanation of Responses:
1. This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 3, 2025.
2. The price range for the aggregate amount sold by the direct holder is $165.00 - $165.06. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
3. Represents shares of restricted stock units issued to the filing person on February 10, 2025. The restricted stock units vest over three years (1/3 on February 10, 2026, 1/3 on February 10, 2027 and 1/3 on February 10, 2028). Of the 9,424 shares, 3,141 shares were issued on February 10, 2026, of which 1,413 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 6,283 shares are scheduled to be issued on the two remaining vesting dates and taxes for these future issuances will be withheld and reported at the time the shares are issued.
4. Represents restricted stock units issued to the filing person on February 10, 2026. This award of restricted stock units vests over three years (1/3 on each anniversary of the award date).
5. The common stock number referred in Table I is an aggregate number and represents 139,785 shares of common stock and 17,204 unvested restricted stock units ("RSUs"), and 18,211 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
6. The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.
7. The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
8. These options are fully vested
/s/ Octavia N. Spencer, Attorney-in-fact 02/12/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did ICE president Benjamin Jackson do in this Form 4 filing for ICE?

Benjamin Jackson exercised 12,861 stock options, received 12,861 ICE common shares, sold 12,861 shares in an open-market trade, had 1,413 shares withheld for taxes, and received 10,921 new restricted stock units that vest over three years.

How many Intercontinental Exchange (ICE) shares did Benjamin Jackson sell and at what price?

Benjamin Jackson sold 12,861 ICE common shares in an open-market transaction at about $165.001 per share. The filing notes a broader sale price range of $165.00 to $165.06 for the aggregate amount sold by the direct holder.

What stock option exercise did Benjamin Jackson report for ICE in this Form 4?

He reported exercising 12,861 employee stock options with an exercise price of $57.31 per share, receiving 12,861 ICE common shares. The options were fully vested at the time of exercise, and the derivative position shows 12,862 options remaining afterward.

What restricted stock activity did Benjamin Jackson report for ICE?

The filing shows 1,413 ICE shares withheld to pay taxes on previously granted restricted stock units and a new award of 10,921 restricted stock units. The new RSUs vest in three equal annual installments, one-third on each anniversary of the February 10, 2026 award date.

Was Benjamin Jackson’s ICE share sale part of a Rule 10b5-1 trading plan?

Yes. The filing states the transaction was effected under a Rule 10b5-1 trading plan that was approved and became effective on November 3, 2025. Such plans pre-schedule trades, helping separate them from short-term market or company news considerations.

How many Intercontinental Exchange (ICE) equity interests does Benjamin Jackson hold after these transactions?

After the reported transactions, Benjamin Jackson beneficially holds 175,200 ICE equity interests. According to the footnotes, this aggregate figure combines common stock, unvested restricted stock units, and performance-based restricted stock units whose performance conditions have been satisfied.